Skip to main content
SpringerLink
Log in

Aspirin and Reye’s Syndrome

A Reappraisal

  • Leading Article
  • Published:
Medical Toxicology and Adverse Drug Experience Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Brain WR, Hunter D, Turnbull HM. Acute meningo-encephalomyelitis of childhood. Lancet 1: 221–227, 1929

    Article  Google Scholar 

  • Cassidy JT. Basic concepts of drug therapy. In Textbook of pediatric rheumatology pp. 99–113 & 115–116, John Wiley, New York, 1982

    Google Scholar 

  • Cassidy JT. Treatment of children with juvenile rheumatoid arthritis. Editorial. New England Journal of Medicine 314: 1312–1314, 1986

    Article  CAS  Google Scholar 

  • Centers for Disease Control. Reye’s Syndrome — United States, 1985. Morbidity and Mortality Weekly Report 35: 1415–1416, 1986

    Google Scholar 

  • Crocker JFS, Bagnell PC. Reye’s syndrome: a clinical review. Canadian Medical Association Journal 124: 375–382 & 425, 1981

    PubMed  CAS  Google Scholar 

  • Crocker FJS, Renton KW, Lee SH, Rozee KR, Digout SC, et al. Biochemical and morphological characteristics of a mouse model of Reye’s syndrome induced by the interaction of influenza B virus and a chemical emulsifier. Laboratory Investigation 54: 32–40, 1986

    PubMed  CAS  Google Scholar 

  • Giles HMC. Encephalopathy and fatty degeneration of the viscera. Lancet 1: 1075, 1965

    Article  PubMed  CAS  Google Scholar 

  • Hall S, Bellman MH. Reye’s syndrome in Great Britain: British Reye’s Syndrome Surveillance Scheme methodology — results. In Pollack (Ed.) Reye’s syndrome IV. National Reye’s Syndrome Foundation, Bryan, Ohio, 1985

    Google Scholar 

  • Halpin JT, Holtzhauer FJ, Campbell RJ, Hall LJ, Correa-Villasenor A, et al. Reye’s syndrome and medication use. Journal of the American Medical Association 248: 687–691, 1982

    Article  PubMed  CAS  Google Scholar 

  • Heim T. Fever. In Davis & Dobbing (Eds.) Scientific foundations of paediatrics, 2nd ed., pp. 118–119, William Heinemann, London, 1981

    Google Scholar 

  • Hurwitz ES, Nelson DB, Davis C, Morens D, Schonberger LB. National surveillance for Reye syndrome: a five-year review. Pediatrics 70: 895–900, 1982

    PubMed  CAS  Google Scholar 

  • Hurwitz ES, Barrett MJ, Bregman D, Gunn WJ, Schonberger LB, et al. Public Health Service study on Reye’s syndrome and medications: report of the pilot phase. New England Journal of Medicine 313: 849–857, 1985

    Article  PubMed  CAS  Google Scholar 

  • Johnson GM, Scurletis TD, Carroll NB. A study of sixteen fatal cases of encephalitis-like disease in North Carolina children. North Carolina Medical Journal 24: 464–473, 1963

    PubMed  CAS  Google Scholar 

  • Lichtenstein PK, Heubi JE, Daugherty CC, Farrell MK, Sokol RJ, et al. Grade I Reye’s syndrome: a frequent cause of vomiting and liver dysfunction after varicella and upper-respiratory-tract infection. New England Journal of Medicine 309: 133–139, 1983

    Article  PubMed  CAS  Google Scholar 

  • Mann RD, Reye’s syndrome and aspirin. Journal of the Royal College of General Practitioners 36: 418–421, 1986

    PubMed  CAS  Google Scholar 

  • Nelson DB, Kimbrough R, Landrigan PS, Hayes AW, Yang GC, Benanides J. Aflatoxin and Reye’s syndrome: a case control study. Pediatrics 66: 865–869, 1980

    PubMed  CAS  Google Scholar 

  • Partin JC, Schubert WK & Partin JS. Mitochondrial ultrastructure in Reye’s syndrome (encephalopathy and fatty degeneration of the viscera). New England Journal of Medicine 285: 1339–1343, 1971

    Article  PubMed  CAS  Google Scholar 

  • Remington PL, Rowley D, McGee H, Hall WN, Monto AS. Decreasing trends in Reye syndrome and aspirin use in Michigan, 1979 to 1984. Pediatrics 77: 93–98, 1986

    PubMed  CAS  Google Scholar 

  • Reye RDK, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera: a disease entity in childhood. Lancet 2: 749–752, 1963

    Article  PubMed  CAS  Google Scholar 

  • Ryan NJ, Hogan GR, Hayes AW, Unger PD, Siraj MY. Aflatoxin B1: its role in the etiology of Reye’s syndrome. Pediatrics 64: 71–75, 1979

    PubMed  CAS  Google Scholar 

  • Starko KM, Ray CG, Dominguez LB, Stromberg WL, Woodall DF. Reye’s syndrome and salcylate use. Pediatrics 66: 859–864, 1980

    PubMed  CAS  Google Scholar 

  • Sullivan-Bolyai JZ, Corey L. Epidemiology of Reye’s syndrome. Epidemiological Reviews 3: 1–26, 1981

    CAS  Google Scholar 

  • Waldman RJ, Hall WN, McGee H, Van Amburg G. Aspirin as a risk factor in Reye’s syndrome. Journal of the American Medical Association 247: 3089–3094, 1982

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Professional Secretariat to the Committee on Safety of Medicines, London, UK

    A. Mary Glen-Bott

Authors
  1. A. Mary Glen-Bott
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glen-Bott, A.M. Aspirin and Reye’s Syndrome. Med Toxicol Adverse Drug Exp 2, 161–165 (1987). https://doi.org/10.1007/BF03259861

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259861

Keywords

Search

Navigation